In multiethnic populations, exposure to per- and polyfluoroalkyl substance (PFAS) mixtures may be associated with increased odds of type 2 diabetes (T2D).

Moderate-to-vigorous physical activity (MVPA) decreases from young adulthood into middle age, with accelerated declines seen within 2 years prior to a cardiovascular disease (CVD) event.

The FDA has approved Skytrofa (lonapegsomatropin-tcgd) for the replacement of growth hormone in adults with GHD.

The US Department of Health and Human Services, US Department of Agriculture, and US Food and Drug Administration are gathering data to create a uniform definition of ultra-processed foods.

Hybrid closed-loop systems were associated with improved glycemic control and safety during prolonged daytime fasting in type 1 diabetes.

In patients with T2D, sodium-glucose cotransporter-2 inhibitors better decrease risk for incident peripheral artery disease compared with DPP4is.

RET carriers with moderate-risk variants had lower penetrance rates of medullary thyroid cancer than suggested by clinical studies.

For patients with heart failure and severe mitral regurgitation (MR) undergoing transcatheter edge-to-edge repair (M-TEER), baseline atrial fibrillation (AF) is associated with more frequent MR ...

The FDA has extended the review period for elinzanetant for the treatment of moderate to severe vasomotor symptoms due to menopause.

Antiobesity medications (AOMs) yield weight loss during use, followed by weight regain after discontinuation of treatment.

From 2023 to 2024, there was a 1% increase in the number of births and a 1% decrease in the general fertility rate.

From 2010 to 2023, physician exit rates from traditional Medicare increased, according to a study published online.